iMetabolic Biopharma Corp

CIK 1957114 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for iMetabolic Biopharma Corp.

Recent SEC filings

FiledFormAccession number
May 6, 2026C-AR0001957114-26-000001
Jul 19, 2024C-AR0001665160-24-001088
Jul 10, 2023C-U0001665160-23-001496
Apr 27, 2023C-AR0001665160-23-000924
Apr 24, 2023C/A0001665160-23-000746
Mar 15, 2023C/A0001665160-23-000414
Dec 28, 2022C/A0001665160-22-003127
Dec 16, 2022C0001665160-22-003084